DNA evidence of plague found in Central Asia
On Oct. 15, 2022, scientists reported that DNA evidence showed that the plague infection was endemic in the…
On Oct. 15, 2022, scientists reported that DNA evidence showed that the plague infection was endemic in the…
On Oct. 13, 2022, Novavax announced positive results from the Phase 1/2 clinical trial of its COVID-19-Influenza Combination…
On Oct. 13, 2022, Pfizer and BioNTech announced early data from a Phase 2/3 clinical trial (NCT05472038) evaluating…
On Oct. 13, 2022, a team of researchers led by Cornell University announced they had sequenced the Honeycrisp…
On Oct. 13, 2022, researchers from the University of Oxford reported findings from a study exploring how certain…
On Oct. 12, 2022, the Fred Hutchinson Cancer Center (FHCRC) announced the Bezos family had committed $710.5 million…
On Oct. 12, 2022, Moderna announced that it had received emergency use authorization from the U.S. Food and…
On Oct. 12, 2022, Pfizer and BioNTech announced that the U.S. Food and Drug Administration granted Emergency Use…
On Oct. 12, 2022, scientists announced they had developed a research method that allows for a much more…
On Oct. 11, 2022, Roche announced the launch of its next-generation portfolio SARS-CoV-2 rapid antigen tests (モ2.0ï¾”) for…
On Oct. 11, 2022, researchers from the University of Oxford have reported new findings from a Phase 1…
On Oct. 10, 2022, Novavax announced that partner, SK bioscience, had submitted a Post Approval Change Application to…
On Oct. 10, 2022, Novavax announced that Switzerland’s Federal Office of Public Health had recommended Nuvaxovid (NVX-CoV2373) as…
On Oct. 10, 2022, the Mayo Clinic announced that The Fred C. and Katherine B. Andersen Foundation of…
On Oct. 7, 2022, the U.S. Food and Drug Administration approved Boostrix (Tetanus Toxoid, Reduced Diphtheria Toxoid and…
On Oct. 7, 2022, the U.S. Food and Drug Administration issued an Emergency Use Authorizationto Abbott Molecular, Inc.,…
On Oct. 7, 2022, Pfizer and BioNTech announced that Health Canada had authorized COMIRNATY Original & Omicron BA.4/BA.5…
On Oct. 7, 2022, the National Eye Institute researchers announced they had mapped the organization of human retinal…
On Oct. 7, 2022, the U.S. Department of Agricultureï¾’s Animal Plant Health Inspection Service confirmed the presence of…
On Oct. 6, 2022, researchers in Japan released a study that described the development and application of the…
On Oct. 6, 2022, Merck announced data from two real-world evidence studies evaluating LAGEVRIOï¾™ (molnupiravir), an investigational oral…
On Oct. 6, 2022, the World Health Organization announced the first cholera outbreak in nearly three decades in…
On Oct. 5, 2022, researchers at UC Berkeley reported that coccidioidomycosisï¾—also known as Valley feverï¾—an infectious disease, was…
On Oct. 5, 2022, the Nobel Prize in Chemistry was awarded jointly to Carolyn R. Bertozzi, Morten Meldal…
On Oct. 4, 2022, Washington University in St. Louis announced it had licensed the rights to develop, manufacture…
On Oct. 4, 2022, the USDA’s Agricultural Research Service (ARS), Southeast Poultry Research Laboratory, opened its new research…
On Oct. 3, 2022, the Nobel Prize in Physiology or Medicine was awarded to was awarded to Svante…
On Oct. 3, 2022, Monica M. Bertagnolli, M.D., started as the 16th director of the National Cancer Institute….
On Sept. 30, 2022, the U.S. Food and Drug Administration Modernization Act reauthorized the Prescription Drug User Fee…
On Sept. 29, 2022, the World Health Organization announced that it had identified the spread of Anopheles stephensi…